Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 497.50 GBp
Change Today 0.00 / 0.00%
Volume 3.2K
IVO On Other Exchanges
Symbol
Exchange
London
Berlin
As of 11:35 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by IMPERIAL INNOVATIONS GROUP P (IVO) in the last 6 months

Announced 08/4/15
3.00M for Oxford Biotrans Ltd.
Private Placement

Oxford Biotrans Ltd announced that it has received £2.5 million in its series A round of equity funding led by existing investor Imperial Innovations Group plc on August 4, 2015. The transaction also includes participation from existing investors IP Group Plc and University Of Oxford, Endowment Arm, and new investors Oxford Innovations and Technology EIS fund and De Monchy Aromatics Limited. Imperial Innovations Group plc invested £1.25 million in this round. Imperial ...
Read More


IVO's price was unchanged after the transaction was announced on 08/4/15.
Investor / Buyer
De Monchy Aromatics Limited
Imperial Innovations Group plc
IP Group Plc
University Of Oxford, Endowment Arm
 
Announced 07/28/15
1.00M for Inflowmatix Limited
Private Placement

Inflowmatix announced that it has raised £1 million in its seed round of funding from new investor Imperial Innovations Group plc on July 28, 2015. As a part of the transaction, the investor acquired 42.5% stake in the company. David Parker, Venture Partner at Imperial Innovations Group plc, joined the company’s board of directors as Chairman.


IVO's price was unchanged after the transaction was announced on 07/28/15.
Investor / Buyer
Imperial Innovations Group plc
 
Announced 07/27/15
3.00M for Concirrus Ltd
Private Placement

Concirrus Ltd announced that it has received £3 million in an equity round of funding on July 27, 2015. The transaction included participation from new investor Imperial Innovations Group plc for acquiring 28.6% stake in the company. As part of the transaction, Kelsey Lynn Skinner and Chris Gomersall from Imperial Innovations Group plc has joined the company's board of directors.


IVO's price was unchanged after the transaction was announced on 07/27/15.
Investor / Buyer
Imperial Innovations Group plc
 
Announced 07/2/15
4.00M for Impression Technologies Limited
Private Placement

Impression Technologies Limited announced that it has received £4 million in funding led by existing investor Imperial Innovations Group plc on July 2, 2015. The transaction also included participation from existing investor Mercia Technologies PLC. Mercia Technologies PLC invested £1.5 million and holds 18% stake in the company and Imperial Innovations Group plc invested £2.5 million and holds a total stake of 59.9% in the company.


IVO's price was unchanged after the transaction was announced on 07/2/15.
Investor / Buyer
Imperial Innovations Group plc
Mercia Technologies PLC
 
Announced 06/30/15
3.00M for Abingdon Health Ltd
Private Placement

Abingdon Health Ltd announced that it has received £3 million in equity funding led by existing investor Imperial Innovations Group plc on June 30, 2015. Imperial Innovations Group plc contributed £2.5 million to the round and holds 33.7% stake in the company.


IVO's price was unchanged after the transaction was announced on 06/30/15.
Investor / Buyer
Imperial Innovations Group plc
 
Announced 06/3/15
8.00M for Auspherix Pty Ltd
Private Placement

Auspherix Pty Ltd announced that it has received £8,150,000 in equity funding led by Imperial Innovations Group plc on June 3, 2015. The transaction also included participation from existing investor MRCF IIF, L.P., a fund managed by Brandon Capital Partners. Imperial Innovations Group plc acquired 27.5% stake in the company through the transaction. As part of the round, Roberto Solari of Imperial Innovations Group plc has joined the company’s board of directors. ...
Read More


IVO's price was unchanged after the transaction was announced on 06/3/15.
Investor / Buyer
Brandon Capital Partners
Imperial Innovations Group plc
MRCF IIF, L.P.
 
Announced 05/26/15
2.00M for Epigeum Ltd
Merger/Acquisition

Oxford University Press Ltd. acquired 17.8% stake in Epigeum Ltd. from Imperial Innovations Group plc (AIM:IVO) for £1.9 million in cash on May 26, 2015. Adrian Duffield/Melanie Toyne-Sewell of Instinctif Partners acted as PR advisor, Michael Wentworth Stanley and Alec Pratt of J.P. Morgan Cazenove and Christopher Golden of Cenkos Securities plc acted as financial advisors to Imperial Innovations Group plc. Anya Cummins of Cavendish Corporate Finance acted as financial ...
Read More


IVO's price was unchanged after the transaction was announced on 05/26/15.
Investor / Buyer
Oxford University Press Ltd.
Creditor / Lender
Imperial Innovations Group plc
 
Announced 05/19/15
25.00M for PsiOxus Therapeutics, Ltd.
Private Placement

PsiOxus Therapeutics, Ltd. announced that it has received £25 million in its series C round of funding led by returning investor Imperial Innovations Group plc on May 19, 2015. The transaction also included participated from returning investors, Invesco Perpetual, SR One, Lundbeckfond Ventures, a fund managed by Lundbeckfond Invest A/S, new investor Mercia Growth Fund 2, a fund managed by returning investor Mercia Fund Management, and new investor Woodford Investment ...
Read More


IVO's price was unchanged after the transaction was announced on 05/19/15.
Investor / Buyer
Imperial Innovations Group plc
Invesco Perpetual
Lundbeckfond Invest A/S
Lundbeckfond Ventures
Mercia Fund Management
Mercia Growth Fund 2
SR One
Woodford Investment Management LLP
 
Announced 04/15/15
6.00M for JustYoyo Ltd.
Private Placement

JustYoyo Ltd. announced that it has received £5.90 million in its series A round of funding led by existing investor Imperial Innovations Group plc on April 15, 2015. The transaction included participation from a number of angel investors Phillip Riese, Jonathan Weiner, Anil Aggarwal, Michael Tobin OBE, and Taavet Hinrikus. Imperial Innovations Group plc invested £5 million in the transaction, representing a stake of 15.2% in the company's issued and outstanding share ...
Read More


IVO's price was unchanged after the transaction was announced on 04/15/15.
Investor / Buyer
Imperial Innovations Group plc
Financial Advisor
J.P. Morgan Cazenove Limited
 
Announced 03/13/15
2.00M for Cortexica Vision Systems Limited
Private Placement

Cortexica Vision Systems Limited announced that it has received £2.3 million in funding from returning investor, Imperial Innovations Group plc on March 13, 2015. The company issued convertible loan in the transaction.


IVO's price was unchanged after the transaction was announced on 03/13/15.
Investor / Buyer
Imperial Innovations Group plc
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IVO:LN 497.50 GBp 0.00

IVO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Health Discovery Corp $0.03 USD 0.00
MDxHealth €4.13 EUR +0.18
Miraculins Inc C$0.06 CAD 0.00
Myriad Genetics Inc $37.56 USD +1.13
Vermillion Inc $2.04 USD +0.10
View Industry Companies
 

Industry Analysis

IVO

Industry Average

Valuation IVO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 141.5x
Price/Book 1.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 142.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMPERIAL INNOVATIONS GROUP P, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.